The subject of the order is the delivery of the medicinal product Polatuzumab vedotin, as part of the Emergency Access to Drug Technologies, detailed in Annex 2 to SWZ.

The subject of the order is the delivery of the medicinal product Polatuzumab vedotin, as part of the Emergency Access to Drug Technologies, detailed in Annex 2 to SWZ